A study published in The Lancet Regional Health – Europe reveals insights into delays in cancer diagnosis for children and young people in the UK.
The research led by Dr. Sharna Shanmugavadivel quantified intervals and routes to diagnosis, highlighting disparities and challenges in diagnostic timing.
Ethnicity, sex, and socioeconomic status did not influence diagnostic timing significantly, but teenagers and certain cancer types faced notable delays.
The median diagnostic interval across all participants was 4.6 weeks, varying based on age groups and cancer types.
Adolescents aged 15-18 experienced the longest median interval of 8.7 weeks, while infants under one year had the shortest at 3.7 weeks.
Bone tumors had the longest diagnostic duration at 12.6 weeks, while kidney tumors were diagnosed most rapidly at 2.3 weeks.
Most pediatric cancer patients had multiple medical consultations before diagnosis, with 67% diagnosed in emergency settings.
Certain cancers like Langerhans Cell Histiocytosis and bone tumors had higher frequencies of medical visits before diagnosis, contributing to delays.
The study emphasizes the need for enhanced clinical vigilance, especially in primary care and emergency medicine.
The findings serve as a foundation for policy development and healthcare strategies to accelerate diagnoses and improve treatment outcomes.